N,N’-Bis-boc-1-guanylpyrazole

We are N,N’-Bis-boc-1-guanylpyrazole CAS:152120-54-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N,N'-Bis-boc-1-guanylpyrazole
CAS.NO:152120-54-2
Synonyms:N,N'-Bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxa;tert-Butyl [(Boc-amino)(1H-pyrazol-1-yl)methylene]carbamate;Pyrazol(Boc)2
Molecular Formula:C14H22N4O4
Molecular Weight:310.34900
 
Physical and Chemical Properties:
Density:1.16;
Melting point:86-90oC;
Index of Refraction:1.525;
 
HS Code: 2933199090
 
Specification:
Appearance:White powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent

N,N'-Bis-boc-1-guanylpyrazole


Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.4-nitroheptanedial CAS:147189-43-3 It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.2440-22-4 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.443-86-7 China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.

Related Products
Product Name
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one View Details
2-Methoxy-4-nitroaniline View Details
2,6-Dichloro-4-(trifluoromethyl)phenylhydrazine View Details
(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride manufacturer 4-Bromo-3-methylbenzoic acid manufacturer 3-Amino-4-chlorobenzotrifluoride manufacturer (2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile manufacturer Estra-5(10),9(11)-diene-3,17-dione 3-Ethylene Ketal manufacturer